loadpatents
name:-0.032195091247559
name:-0.029923915863037
name:-0.00055503845214844
Grundschober; Christophe Patent Filings

Grundschober; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grundschober; Christophe.The latest application filed is for "v1a antagonists to treat phase shift sleep disorders".

Company Profile
0.29.44
  • Grundschober; Christophe - Rodersdorf CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
V1A antagonists to treat phase shift sleep disorders
Grant 10,265,327 - Schnider , et al.
2019-04-23
Peptides as oxytocin agonists
Grant 9,957,298 - Bissantz , et al. May 1, 2
2018-05-01
V1a Antagonists To Treat Phase Shift Sleep Disorders
App 20180064727 - Schnider; Patrick ;   et al.
2018-03-08
Peptides as oxytocin agonists
Grant 9,868,766 - Bissantz , et al. January 16, 2
2018-01-16
Oxytocin receptor agonists for the treatment of CNS diseases
Grant 9,751,870 - Bissantz , et al. September 5, 2
2017-09-05
Peptides As Oxytocin Agonists
App 20170081369 - Bissantz; Caterina ;   et al.
2017-03-23
Peptides As Oxytocin Agonists
App 20170081368 - Bissantz; Caterina ;   et al.
2017-03-23
Oxytocin receptor agonists for the treatment of CNS diseases
App 20150322058 - Bissantz; Caterina ;   et al.
2015-11-12
Peptides As Oxytocin Agonists
App 20150284434 - Bissantz; Caterina ;   et al.
2015-10-08
Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
Grant 8,580,821 - Grundschober , et al. November 12, 2
2013-11-12
Spiro-piperidine derivatives
Grant 8,202,993 - Bissantz , et al. June 19, 2
2012-06-19
Indoles
Grant 8,143,281 - Bissantz , et al. March 27, 2
2012-03-27
Indol-3-y-carbonyl-piperidin And Piperazin-derivatives
App 20120040990 - Bissantz; Caterina ;   et al.
2012-02-16
Spiropiperidine derivatives
Grant 8,084,609 - Bissantz , et al. December 27, 2
2011-12-27
Indoles
Grant 8,076,360 - Bissantz , et al. December 13, 2
2011-12-13
Indoles
Grant 8,071,622 - Bissantz , et al. December 6, 2
2011-12-06
Azaspiro derivatives
Grant 8,044,202 - Bissantz , et al. October 25, 2
2011-10-25
Azaspiro derivatives
Grant 8,039,624 - Bissantz , et al. October 18, 2
2011-10-18
Azaspiro derivatives
Grant 8,034,937 - Bissantz , et al. October 11, 2
2011-10-11
Indoles
Grant 8,026,259 - Bissantz , et al. September 27, 2
2011-09-27
Spiro-piperidine derivatives
Grant 8,022,213 - Bissantz , et al. September 20, 2
2011-09-20
Serotonin Transporter (sert) Inhibitors For The Treatment Of Depression And Anxiety
App 20110105561 - Grundschober; Christophe ;   et al.
2011-05-05
Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
Grant 7,872,022 - Grundschober , et al. January 18, 2
2011-01-18
Indol-3-yl-carbonyl-piperidin-benzoimidazol Derivatives
App 20100256140 - Bissantz; Caterina ;   et al.
2010-10-07
Indol-3-yl-corbonyl-piperidin-benzoimidazol derivatives
Grant 7,803,815 - Bissantz , et al. September 28, 2
2010-09-28
Indoles
Grant 7,799,923 - Bissantz , et al. September 21, 2
2010-09-21
Indol-3-yl-carbonyl-azaspiro derivatives
Grant 7,790,752 - Bissantz , et al. September 7, 2
2010-09-07
Indol-3-y-carbonyl-piperidin And Piperazin-derivatives
App 20100222357 - Bissantz; Caterina ;   et al.
2010-09-02
Indol-3-y-carbonyl-piperidin and piperazin-derivatives
Grant 7,781,436 - Bissantz , et al. August 24, 2
2010-08-24
Spiro-piperidine derivatives
Grant 7,678,806 - Bissantz , et al. March 16, 2
2010-03-16
Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonists
Grant 7,629,353 - Bissantz , et al. December 8, 2
2009-12-08
Spiro-piperidine derivatives
Grant 7,501,432 - Bissantz , et al. March 10, 2
2009-03-10
Spiropiperidine glycinamide derivatives
Grant 7,498,339 - Bissantz , et al. March 3, 2
2009-03-03
Spiro-piperidine derivatives
Grant 7,495,008 - Bissantz , et al. February 24, 2
2009-02-24
Azaspiro Derivatives
App 20080281103 - Bissantz; Caterina ;   et al.
2008-11-13
Spiro-piperidine derivatives
App 20080280898 - Bissantz; Caterina ;   et al.
2008-11-13
Indoles
App 20080269290 - Bissantz; Caterina ;   et al.
2008-10-30
Spiro-piperidine derivatives
Grant 7,432,259 - Bissantz , et al. October 7, 2
2008-10-07
Spiropiperidine Glycinamide Derivatives
App 20080194610 - Bissantz; Caterina ;   et al.
2008-08-14
Spiropiperidine Glycinamide Derivatives
App 20080171760 - Bissantz; Caterina ;   et al.
2008-07-17
Spiropiperidine Glycinamide Derivatives
App 20080171759 - Bissantz; Caterina ;   et al.
2008-07-17
Indoles
App 20080167344 - Bissantz; Caterina ;   et al.
2008-07-10
New Solid Forms Of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesul- Fonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone
App 20080167333 - Bissantz; Caterina ;   et al.
2008-07-10
Indoles
App 20080161316 - Bissantz; Caterina ;   et al.
2008-07-03
Azaspiro Derivatives
App 20080161333 - Bissantz; Caterina ;   et al.
2008-07-03
Indoles
App 20080161315 - Bissantz; Caterina ;   et al.
2008-07-03
Spiro-piperidine Derivatives
App 20080161299 - Bissantz; Caterina ;   et al.
2008-07-03
Spiro-piperidine derivatives
App 20080161304 - Bissantz; Caterina ;   et al.
2008-07-03
Spiro-piperidine Derivatives
App 20080161298 - Bissantz; Caterina ;   et al.
2008-07-03
Azaspiro Derivatives
App 20080161332 - Bissantz; Caterina ;   et al.
2008-07-03
Spiropiperidine Derivatives
App 20080153863 - Bissantz; Caterina ;   et al.
2008-06-26
Spiropiperidine Derivatives
App 20080153862 - Bissantz; Caterina ;   et al.
2008-06-26
Spiropiperidine Derivatives
App 20080153861 - Bissantz; Caterina ;   et al.
2008-06-26
INDOL-3-YL-CARBONYL-SPIRO-PIPERIDINE DERIVATIVES AS VIa RECEPTOR ANTAGONISTS
App 20080146557 - Bissantz; Caterina ;   et al.
2008-06-19
Spiro-piperidine Derivatives
App 20080146568 - Bissantz; Caterina ;   et al.
2008-06-19
Spiro-piperidine Derivatives
App 20080139553 - Bissantz; Caterina ;   et al.
2008-06-12
Indoles
App 20080139548 - Bissantz; Caterina ;   et al.
2008-06-12
Indoles
App 20080139618 - Bissantz; Caterina ;   et al.
2008-06-12
Spiro-piperidine Derivatives
App 20080139554 - Bissantz; Caterina ;   et al.
2008-06-12
Indoles
App 20080139550 - Bissantz; Caterina ;   et al.
2008-06-12
Indoles
App 20080139552 - Bissantz; Caterina ;   et al.
2008-06-12
Indoles
App 20080139617 - Bissantz; Caterina ;   et al.
2008-06-12
Indoles
App 20080139549 - Bissantz; Caterina ;   et al.
2008-06-12
Indol-3-yl-carbonyl-spiro-piperidine derivatives
Grant 7,351,706 - Bissantz , et al. April 1, 2
2008-04-01
Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonists
Grant 7,332,501 - Bissantz , et al. February 19, 2
2008-02-19
Serotonin transporter (sert) inhibitors for the treatment of depression and anxiety
App 20070232652 - Grundschober; Christophe ;   et al.
2007-10-04
Indol-3-yl-carbonyl-spiro-piperidine derivatives
App 20070155761 - Bissantz; Caterina ;   et al.
2007-07-05
Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
App 20070129419 - Grundschober; Christophe ;   et al.
2007-06-07
Indol-3-yl-carbonyl-azaspiro derivatives
App 20070072888 - Bissantz; Caterina ;   et al.
2007-03-29
Indol-3-y-carbonyl-piperidin and piperazin-derivatives
App 20070027163 - Bissantz; Caterina ;   et al.
2007-02-01
Indol-3-yl-carbonyl-spiro-piperidine derivatives as Vla receptor antagonists
App 20070027173 - Bissantz; Caterina ;   et al.
2007-02-01
Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
App 20070021463 - Bissantz; Caterina ;   et al.
2007-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed